Effect of biofeedback, psyllium and polyethylene glycol in treating constipation due to dyssynergia

Comparison of biofeedback, biofeedback plus fiber laxative, and biofeedback plus osmotic laxative for treatment of constipation in patients with pelvic floor dyssynergia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191030045274N1

Enrollment

105

Registered

2020-01-11

Start date

2018-02-20

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation due to pelvic floor dyssynergia.

Interventions

Intervention 1: Intervention group: First group: Patients who are assigned to do biofeedback exercises and also receive 15 grams of psyllium powder twice daily for three weeks. Intervention 2: Interve

Eligibility

Sex/Gender

All

Age

15 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who had history or signs of constipation due to dyssynergia which were confirmed by anorectal maometery

Exclusion criteria

Exclusion criteria: Patients who had constipation due to secondary causes such as using opioids, endocrine diseases, neurologic diseases, history of surgery, etc.

Design outcomes

Primary

Measure	Time frame
Wellbeing by patient. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Medication use to evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Digitation to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Difficulties to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Return to toilet to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Feeling of incomplete evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Straining to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Time needed to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Life style alteration. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Rectal bleeding. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.	—

Measure

Time frame

Wellbeing by patient. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Medication use to evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Digitation to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Difficulties to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Return to toilet to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Feeling of incomplete evacuation. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Straining to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Time needed to evacuate. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Life style alteration. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.;Rectal bleeding. Timepoint: in the beginning of study and three weeks after treatment. Method of measurement: asking the patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHabib Malekpour

Shahid Beheshti University of Medical Sciences

habib.malekpour@gmail.com+98 21 7343 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026